VENMAX exchange filings, corporate actions and results
1 Sep 2026
⚑ Filing
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Reg. 34 (1) Annual Report.BSE filing · raw filing ↗
31 Aug 2026
⚑ Filing
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE filing · raw filing ↗
24 Aug 2026
⚑ Filing
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
